Perceptive LIFE Sciences Master FUND Ltd., Director at Cerevel Therapeutics Holdings, Inc. (CERE), bought 200,000 shares at $25.00 ($5.0M) on 2021-07-07, disclosed to the SEC on 2021-07-09.
Open-market purchase of $5.0M CERE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |